{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-057768","form_type":"8-K","ticker":"ICCC","cik":"0000811641","company_name":"IMMUCELL CORP /DE/","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.362057+00:00","generated_at":"2026-05-18T21:46:09.172093+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ImmuCell CEO Michael Brigham plans retirement by early 2026; board launches succession search","bullets":["President/CEO Michael Brigham (65) intends to retire from full-time work by early 2026; board has started successor search.","Brigham's prior CFO responsibilities transferred to recently hired CFO Timothy C. Fiori.","Goal to identify new CEO candidate by around year-end 2025; Brigham will stay until transition complete.","Brigham to remain on board through term ending June 2026 and beyond, subject to stockholder vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-057768","json":"https://secwatch.observer/filing/0001213900-25-057768.json","markdown":"https://secwatch.observer/filing/0001213900-25-057768.md","text":"https://secwatch.observer/filing/0001213900-25-057768.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/811641/000121390025057768/0001213900-25-057768-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811641/000121390025057768/ea0247006-8k_immucell.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T21:46:09.172093+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}